RECURRENT OVARIAN-CARCINOMA - DIAGNOSIS AND 2ND-LINE THERAPY

Citation
M. Geary et al., RECURRENT OVARIAN-CARCINOMA - DIAGNOSIS AND 2ND-LINE THERAPY, Irish medical journal, 88(2), 1995, pp. 68-70
Citations number
NO
Categorie Soggetti
Medicine, General & Internal
Journal title
ISSN journal
03323102
Volume
88
Issue
2
Year of publication
1995
Pages
68 - 70
Database
ISI
SICI code
0332-3102(1995)88:2<68:RO-DA2>2.0.ZU;2-Z
Abstract
Approximately 10% of patients with ovarian cancer will develop a recur rence. Successful treatment of recurring disease has been documented, and recent developments in chemotherapy are encouraging. In our study, CA125 Tumour Marker was a useful marker to monitor the course of such disease, and detected recurring ovarian cancer at a sub-clinical leve l, leading to earlier diagnosi. This may have implications for outcome .